Pharvaris PHVS
NASDAQ PHVS
$30.83 -0.07 (-0.24%)
As of: Oct 21, 2026 · 12:59 PM EDT

Pharvaris (PHVS) Receivables - Other (2025)

Updated

Analysis

Pharvaris (PHVS) Receivables - Other (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn
10 Pharvaris 1.83 Bn 452.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.47 Mn
API Access

Pharvaris Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PHVS&period=max&api_key=YOUR_API_KEY